Rui-Yan Wu

835 total citations
8 papers, 575 citations indexed

About

Rui-Yan Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Rui-Yan Wu has authored 8 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Epidemiology. Recurrent topics in Rui-Yan Wu's work include Autophagy in Disease and Therapy (2 papers), Cancer-related gene regulation (2 papers) and Adenosine and Purinergic Signaling (1 paper). Rui-Yan Wu is often cited by papers focused on Autophagy in Disease and Therapy (2 papers), Cancer-related gene regulation (2 papers) and Adenosine and Purinergic Signaling (1 paper). Rui-Yan Wu collaborates with scholars based in China. Rui-Yan Wu's co-authors include Xiao‐Feng Zhu, Rong Deng, Xuan Li, Gong-Kan Feng, Hai‐Liang Zhang, Yan Yu, Jiao Ji, Lin Jiao, Dandan Li and Ravichandran Senthilkumar and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and Autophagy.

In The Last Decade

Rui-Yan Wu

8 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rui-Yan Wu China	8	292	236	165	135	57	8	575
Lina Sun China	13	519 1.8×	82 0.3×	301 1.8×	78 0.6×	24 0.4×	17	670
Shi‐Juan Mai China	15	375 1.3×	53 0.2×	225 1.4×	133 1.0×	38 0.7×	32	572
Guodong Xiao China	17	559 1.9×	123 0.5×	394 2.4×	169 1.3×	52 0.9×	39	781
Wei‐Hwa Lee Taiwan	11	209 0.7×	87 0.4×	86 0.5×	123 0.9×	41 0.7×	26	464
Mengjie Yan China	7	191 0.7×	87 0.4×	90 0.5×	122 0.9×	27 0.5×	10	422
Beatrice Conti Italy	10	215 0.7×	144 0.6×	83 0.5×	61 0.5×	96 1.7×	14	431
Kunal Shah United Kingdom	12	213 0.7×	90 0.4×	119 0.7×	92 0.7×	25 0.4×	19	535
Jenna D. Lovaas United States	5	215 0.7×	80 0.3×	96 0.6×	111 0.8×	20 0.4×	6	454
Olivia Adams Switzerland	7	325 1.1×	254 1.1×	66 0.4×	83 0.6×	44 0.8×	10	508

Countries citing papers authored by Rui-Yan Wu

Since Specialization

Citations

This map shows the geographic impact of Rui-Yan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui-Yan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui-Yan Wu more than expected).

Fields of papers citing papers by Rui-Yan Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui-Yan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui-Yan Wu. The network helps show where Rui-Yan Wu may publish in the future.

Co-authorship network of co-authors of Rui-Yan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Rui-Yan Wu. A scholar is included among the top collaborators of Rui-Yan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui-Yan Wu. Rui-Yan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Wu, Rui-Yan, Pengfei Kong, Liang-Ping Xia, et al.. (2019). Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma. Clinical Cancer Research. 25(14). 4530–4541. 80 indexed citations

2.

Mai, Jia, Guifang Guo, Yan‐Qun Xiang, et al.. (2019). Polo-Like Kinase 1 phosphorylates and stabilizes KLF4 to promote tumorigenesis in nasopharyngeal carcinoma. Theranostics. 9(12). 3541–3554. 30 indexed citations

3.

He, Qiu-ming, Lei Tan, Rui-Yan Wu, et al.. (2017). Overexpression of PTK6 predicts poor prognosis in bladder cancer patients. Journal of Cancer. 8(17). 3464–3473. 18 indexed citations

4.

Jiao, Lin, Hai‐Liang Zhang, Dandan Li, et al.. (2017). Regulation of glycolytic metabolism by autophagy in liver cancer involves selective autophagic degradation of HK2 (hexokinase 2). Autophagy. 14(4). 671–684. 201 indexed citations

5.

Cheng, Hao, Hai‐Liang Zhang, Rui-Yan Wu, et al.. (2016). A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer. Oncotarget. 8(5). 8120–8130. 25 indexed citations

6.

Sun, Ting, Xuan Li, Peng Zhang, et al.. (2015). Acetylation of Beclin 1 inhibits autophagosome maturation and promotes tumour growth. Nature Communications. 6(1). 7215–7215. 181 indexed citations

7.

Yu, Yan, Fen Yang, Rong Deng, et al.. (2015). Inhibition of DNA methyltransferase as a novel therapeutic strategy to overcome acquired resistance to dual PI3K/mTOR inhibitors. Oncotarget. 6(7). 5134–5146. 30 indexed citations

8.

Yu, Yan, Zhenhua Li, Rui-Yan Wu, et al.. (2015). EGFR tyrosine kinase inhibitors promote pro-caspase-8 dimerization that sensitizes cancer cells to DNA-damaging therapy. Oncotarget. 6(19). 17491–17500. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact